These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

86 related items for PubMed ID: 6424456

  • 1. Antibody levels in reduced/alkylated intravenous immune globulin.
    Rousell RH, Collins MS, Dobkin MB, Louie RE, Roby RE, Sweet BH.
    Am J Med; 1984 Mar 30; 76(3A):40-5. PubMed ID: 6424456
    [Abstract] [Full Text] [Related]

  • 2. Comparative opsonic activity of intravenous gamma globulin preparations for common bacterial pathogens.
    Hill HR, Augustine NH, Shigeoka AO.
    Am J Med; 1984 Mar 30; 76(3A):61-6. PubMed ID: 6424458
    [Abstract] [Full Text] [Related]

  • 3. Varicella zoster antibody titers after the administration of intravenous immune serum globulin or varicella zoster immune globulin.
    Paryani SG, Arvin AM, Koropchak CM, Wittek AE, Amylon MD, Dobkin MB, Budinger MD.
    Am J Med; 1984 Mar 30; 76(3A):124-7. PubMed ID: 6324585
    [Abstract] [Full Text] [Related]

  • 4. Antibody against the human immunodeficiency virus in commercial intravenous gammaglobulin preparations.
    Wood CC, Williams AE, McNamara JG, Annunziata JA, Feorino PM, Conway CO.
    Ann Intern Med; 1986 Oct 30; 105(4):536-8. PubMed ID: 2428274
    [Abstract] [Full Text] [Related]

  • 5. Experimental studies of the pathogenesis of infections due to Pseudomonas aeruginosa. Treatment with intravenous immune globulin.
    Holder IA, Naglich JG.
    Am J Med; 1984 Mar 30; 76(3A):161-7. PubMed ID: 6424445
    [Abstract] [Full Text] [Related]

  • 6. Protective and opsonic activities of a native, pH 4.25 intravenous immunoglobulin G preparation against common bacterial pathogens.
    Hill HR, Bathras JM.
    Rev Infect Dis; 1986 Mar 30; 8 Suppl 4():S396-400. PubMed ID: 3092306
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Comparative anti-Pseudomonas aeruginosa activity of chemically modified and native immunoglobulin G (human), and potentiation of antibiotic protection against Pseudomonas aeruginosa and group B Streptococcus in vivo.
    Collins MS, Dorsey JH.
    Am J Med; 1984 Mar 30; 76(3A):155-60. PubMed ID: 6424444
    [Abstract] [Full Text] [Related]

  • 9. Anti-tetanus toxoid antibodies in intravenous gamma globulin: an alternative to tetanus immune globulin.
    Lee DC, Lederman HM.
    J Infect Dis; 1992 Sep 30; 166(3):642-5. PubMed ID: 1500750
    [Abstract] [Full Text] [Related]

  • 10. A preparation of modified immune serum globulin (human) suitable for intravenous administration. Further characterization and comparison with pepsin-treated intravenous gamma globulin.
    Schroeder DD, Dumas ML.
    Am J Med; 1984 Mar 30; 76(3A):33-9. PubMed ID: 6424455
    [Abstract] [Full Text] [Related]

  • 11. Antibodies to hepatitis A virus in immune serum globulin.
    Smallwood LA, Tabor E, Finlayson JS, Gerety RJ.
    J Med Virol; 1981 Mar 30; 7(1):21-7. PubMed ID: 7241098
    [Abstract] [Full Text] [Related]

  • 12. Adverse reactions in selected patients following intravenous infusions of gamma globulin.
    Day NK, Good RA, Wahn V.
    Am J Med; 1984 Mar 30; 76(3A):25-32. PubMed ID: 6231860
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Measles-virus-neutralizing antibodies in intravenous immunoglobulins.
    Audet S, Virata-Theimer ML, Beeler JA, Scott DE, Frazier DJ, Mikolajczyk MG, Eller N, Chen FM, Yu MY.
    J Infect Dis; 2006 Sep 15; 194(6):781-9. PubMed ID: 16941344
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Efficacy and safety of high-dose intravenous immune globulin therapy for antibody deficiency syndromes.
    Sorensen RU, Polmar SH.
    Am J Med; 1984 Mar 30; 76(3A):83-90. PubMed ID: 6424462
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Intravenous immunoglobulin in neonatal group B streptococcal disease. Pharmacokinetic and safety studies in monkeys and humans.
    Fischer GW, Weisman LB, Hemming VG, London WT, Hunter KW, Bosworth JM, Sever JL, Wilson SR, Curfman BL.
    Am J Med; 1984 Mar 30; 76(3A):117-23. PubMed ID: 6424443
    [Abstract] [Full Text] [Related]

  • 19. Phase I study of intravenous gamma globulin in multiple myeloma.
    Gordon DS, Hearn EB, Spira TJ, Reimer CB, Phillips DJ, Schable C.
    Am J Med; 1984 Mar 30; 76(3A):111-6. PubMed ID: 6424442
    [Abstract] [Full Text] [Related]

  • 20. Lack of seroconversion to human T-cell lymphotropic virus, type III, after intravenous immune globulin.
    Bussel JB.
    Transfusion; 1986 Mar 30; 26(4):399. PubMed ID: 3014693
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.